You are here

Luxturna

Traditional gene therapies are uber-niche. Ocugen hopes to change that.

Pharma Voice

Wed, 04/17/24 - 11:14 am

UK cost watchdog recommends Novartis' blindness therapy Luxturna

Yahoo/Reuters

Wed, 09/4/19 - 10:18 am

Spark Therapeutics

The top 10 most-expensive meds in the U.S.—and they're not the usual suspects

Fierce Pharma

Thu, 06/13/19 - 12:14 pm

Spark Therapeutics

JPM19: Spark looks at scale, manufacturing as gene therapy matures

Biopharma Dive

Thu, 01/10/19 - 08:45 pm

Spark Therapeutics

2 Sets of Disasters Biotech Will Pay For in 2019

Yahoo/Motley Fool

Mon, 12/17/18 - 12:16 am

Gilead Sciences

Spark Therapeutics

Luxturna cleared for sale in Europe, but payer support uncertain

Biopharma Dive

Mon, 11/26/18 - 11:15 pm

Spark Therapeutics

Novartis/Spark’s sight gene therapy approved in EU

Pharmaforum

Fri, 11/23/18 - 01:16 pm

Spark Therapeutics

Spark/Novartis eye gene therapy nears EU market – but at what price?

Pharmaforum

Sun, 09/23/18 - 10:36 pm

Spark Therapeutics

Is biopharma’s first $1.5M therapy now in Phase III?

Endpoints

Mon, 05/7/18 - 11:12 am

Spark Therapeutics

‘That’s $425,000 right there’ — the anxious launch of a gene therapy with a record sticker price

Stat

Wed, 03/21/18 - 09:23 am

Spark Therapeutics

Spark lays groundwork for US Luxturna launch

Biopharma Dive

Wed, 02/21/18 - 10:58 pm

Spark Therapeutics

Cost over sight? Spark's blindness cure has the industry talking

Medical Marketing and Media

Fri, 02/2/18 - 09:23 am

Spark Therapeutics

Novartis move signals further gene therapy resurgence

EP Vantage

Fri, 01/26/18 - 11:12 am

Spark Therapeutics

Spark licenses blindness gene therapy rights outside U.S. to Novartis

Yahoo/Reuters

Thu, 01/25/18 - 12:00 am

Spark Therapeutics

Drugmakers see a pricing blueprint in an $850,000 gene therapy

Reuters

Fri, 01/12/18 - 06:30 pm

Spark Therapeutics

Spark prices its gene therapy as most expensive U.S. medicine — but with plans to ease cost concerns

Stat

Wed, 01/3/18 - 11:09 am

Spark Therapeutics

FDA rolls out an early and historic OK for Spark’s pioneering gene therapy

Endpoints

Tue, 12/19/17 - 11:06 am

Spark Therapeutics

retinal dystrophies

We may soon have our first $1 million drug. Who will pay for it? And how?

Stat

Sat, 10/14/17 - 11:04 am

Spark Therapeutics

Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote

Xconomy

Thu, 10/12/17 - 10:22 pm

Spark Therapeutics

advisory panels

Here Come More Gene Therapies -- And More Pricing Debates

Forbes

Wed, 10/11/17 - 10:03 am

Spark Therapeutics

Pages